LOUISVILLE, Ky., June 16, 2011 - RxCrossroads®, an Omnicare company providing specialized solutions specifically tailored to the biotechnology and pharmaceutical industries, today announced the opening of its new National Turnpike Pharma and Bio Logistics Center in Louisville, Kentucky. The new facility is 98,925-square-feet of pharma grade warehouse space and is designed to support growth of the company's third party logistics business. It also has the potential to create dozens of new jobs.
RxCrossroads National Turnpike Pharma and Bio Logistics Center will allow for increased storage of up to 8,000 pallet positions in a controlled room temperature of 20 degrees Celsius to 25 degrees Celsius. Future plans call for adding refrigerated storage of 2 degrees Celsius to 8 degrees Celsius. Space is available for an additional 30,000 square feet storage expansion.
The National Turnpike facility is in addition to the existing 132,000 square foot RxCrossroads facility at Progress Boulevard in Louisville that has controlled room, refrigerated and frozen storage capabilities.
To meet increased market demand, RxCrossroads also has relocated its Plasma Logistics Center to Erlanger, Kentucky from Walton, Kentucky to support products requiring storage at minus 25 degrees Celsius or colder. The Erlanger warehouse is cooled by an ammonia based cooling system having redundancy support from a secondary Freon-based system that is backed up by a diesel generator in the event of a power loss. The new, larger facility will provide 70 percent more storage capacity for frozen products, a 60 percent larger receiving area, and 400 percent increased office space. RxCrossroads also operates of fleet of 26 tractor trailers operating at minus 35 degrees Celsius that service plasma collection centers located throughout the United States.
The Erlanger Plasma Logistics Center and transportation fleet have been certified by the German Health Authority.
"Our expansion is yet another example of our commitment to our customers for storage and distribution of pharmaceutical and biotechnology products requiring strict temperature control and time sensitive delivery," said Nitin Sahney, President, Omnicare's Specialty Care Group. "RxCrossroads is the only vendor to offer an integrated solution that addresses specialty pharmacy, reimbursement support services, and third party logistics for our customers' products under a single management team."
RxCrossroads provides HUB Service Programs encompassing reimbursement support, integration with network pharmacies, patient adherence programs, specialty logistics services, sales operations support and mail-order pharmacy services to pharmaceutical, biotechnology and medical device manufacturers. Through its complement of capabilities, RxCrossroads' solutions incorporate high touch services that provide a consistent patient, prescriber and client experience. RxCrossroads information technology platform integrates information that provides a complete picture for service program analysis. For more information, visit www.rxcrossroads.com.
About Omnicare, Inc.
Omnicare, Inc., a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include specialty pharmacy operations and a wide range of support services for specialty pharmaceuticals. For more information, visit www.omnicare.com.
# # #
Patrick C. Lee
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Omnicare via Thomson Reuters ONE